Cancer R&D

Welcome to the 2026 International Conference on Cancer Research and Development (Cancer R&D 2026), a prestigious three-day congress dedicated to advancing the field of basic, preclinical, and translational cancer research. Hosted by United Scientific Group, a distinguished non-profit organization committed to the progression of cancer research, Cancer R&D serves as a platform to foster innovation, cultivate knowledge, and encourage meaningful connections and collaborations within the global cancer research community. The conference will cover a range of critical topics, including Novel Approaches to Detect Cancer Early, Computational Biology and AI in Cancer, Cancer Immunotherapies: Monotherapy and Combinations, Novel Drug Development in Cancer, and Advances in Organ Specific Cancer Research, with a special focus on Non-Small Cell Lung Cancer.The event will also celebrate excellence in the field, as it honors Prof. Raghu Kalluri with the Lifetime Achievement Award for his relentless dedication and transformative research on the extracellular matrix, which has significantly advanced therapies for cancer, autoimmune disorders, genetic diseases, and organ fibrosis. His pioneering work is shaping the future of cancer research. Cancer R&D 2026 offers a unique opportunity for researchers and professionals to network face to face, building rapport and solid connections in their respective research areas. The previous ten editions of the Cancer R&D conference have successfully brought together over 1,050 researchers from leading institutes and organizations, emphasizing the importance of collaboration in achieving significant advancements in cancer research. Attendees will find a platform to share their ideas and insights, contributing to a collective effort that pushes the boundaries of knowledge in oncology. Join us to present your work and connect with peers in the vibrant world of cancer research.